72
edits
Changes
no edit summary
* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref>
* Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg (once a month) and 960mg (once every two months) preparations. It is possible to administer a A reduced dosage dose of 75% (300mg and 720mg respectively) can be needed when experiencing side effects.
